Intracanalicular corticosteroid insert safe for postsurgical inflammation, pain

Study demonstrates power of IRIS Registry for evaluation of safety, efficacy Although novel ophthalmic medications and delivery systems continue to emerge, many surgeons are hesitant to use them in patients until comprehensive evidence accrues to support their application. [...]when comparing the 2...

Full description

Saved in:
Bibliographic Details
Published inOphthalmology Times Vol. 48; no. 8; pp. 34 - 35
Main Author Mbagwu, Michael
Format Trade Publication Article
LanguageEnglish
Published Monmouth Junction MultiMedia Healthcare Inc 01.08.2023
Subjects
Anniversaries
Cataracts
Clinical trials
Edema
Eye surgery
Glaucoma
Inflammation
Medical personnel
Ophthalmology
Pain
Steroids
Surgeons
Online AccessGet full text

Cover

More Information
Summary:Study demonstrates power of IRIS Registry for evaluation of safety, efficacy Although novel ophthalmic medications and delivery systems continue to emerge, many surgeons are hesitant to use them in patients until comprehensive evidence accrues to support their application. [...]when comparing the 2 arms of our real-world study, patients in the non-Dextenza cohort were more likely to reach IOP levels of 10 mm Hg or more, with a rate of 8.796 the day after surgery. [...]the IRIS Registry's database will be enriched as Dextenza spends more years on the market and is used in more eyes, generating new and helpful information that can be harnessed for future studies.
ISSN:0193-032X
2150-7333